Hinchliffe Report 60th Anniversary Symposium Pharmaceutical policies in the long run:reflections on the 60th anniversary of the Hinchliffe Report History - sustainability of pharmaceutical expenditure then and now Today’s challenges: pricing decisions and opportunity costMr Danny Palnoch, Head of Medicines Analysis, Strategy and Policy, NHS England NHS drug costs: how does the most recent decade compare with the first? Dr Elaine Kelly, Senior Research Economist, Institute for Fiscal Studies and the Health “Restriction on quantitites”: the problem of drug shortages Dr Jeffrey Aronson, Consultant Physician and Clinical Pharmacologist, Nuffield Department of Primary Health Care Sciences Generating and reporting of evidence Clinical trials in the NHS – how did we do? Professor Louise Bowman, Professor of Medicine and Clinical Trials, Nuffield Department of Population Health Clinical trials in the NHS – how can we do more? Professor Martin Landray, Nuffield Department of Population Health Training of medical practitioners & use of evidence based medicine Back to medical school – what I wish I’d learned about health economicsDr Amanda Adler, Chair of NICE Appraisal Committee and Consultant Physician Economics of drug development & marketing The Hinchliffe Report: cost control and the prescription charge Professor Darrin Baines, Professor in Health Economics,, Bournemouth University Costs of R&D and reflections on marketingProfessor Adrian Towse, Office for Health Economics Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to the NHS Dr Beth Woods, Senior Research Fellow, Centre for Health Economics, University of York NICE re-imagined Professor Philip Clarke, Health Economics Research Centre, Nuffield Department of Population Health Closing remarks Professor Sir Rory Collins, Nuffield Department of Population Health